{"id":598843,"date":"2023-01-18T15:53:04","date_gmt":"2023-01-18T21:53:04","guid":{"rendered":"https:\/\/news.sellorbuyhomefast.com\/index.php\/2023\/01\/18\/pfizer-offers-up-entire-drug-and-vaccine-portfolio-to-worlds-poorest-countries-at-non-profit-prices\/"},"modified":"2023-01-18T15:53:04","modified_gmt":"2023-01-18T21:53:04","slug":"pfizer-offers-up-entire-drug-and-vaccine-portfolio-to-worlds-poorest-countries-at-non-profit-prices","status":"publish","type":"post","link":"https:\/\/newsycanuse.com\/index.php\/2023\/01\/18\/pfizer-offers-up-entire-drug-and-vaccine-portfolio-to-worlds-poorest-countries-at-non-profit-prices\/","title":{"rendered":"Pfizer Offers Up Entire Drug And Vaccine Portfolio To World\u2019s Poorest Countries At Non-Profit Prices"},"content":{"rendered":"<div>\n<h2>Topline<\/h2>\n<p>U.S. pharma giant Pfizer on Tuesday <a href=\"https:\/\/investors.pfizer.com\/Investors\/News\/news-details\/2023\/Pfizer-Expands-An-Accord-for-a-Healthier-World-Product-Offering-to-Include-Full-Portfolio-for-Greater-Benefit-to-1.2-Billion-People-in-45-Lower-Income-Countries\/default.aspx\" target=\"_blank\" title=\"https:\/\/investors.pfizer.com\/Investors\/News\/news-details\/2023\/Pfizer-Expands-An-Accord-for-a-Healthier-World-Product-Offering-to-Include-Full-Portfolio-for-Greater-Benefit-to-1.2-Billion-People-in-45-Lower-Income-Countries\/default.aspx\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/investors.pfizer.com\/Investors\/News\/news-details\/2023\/Pfizer-Expands-An-Accord-for-a-Healthier-World-Product-Offering-to-Include-Full-Portfolio-for-Greater-Benefit-to-1.2-Billion-People-in-45-Lower-Income-Countries\/default.aspx\" aria-label=\"said\">said<\/a> it will make its entire portfolio of drugs and vaccines available to low-income countries on a not-for-profit basis, significantly expanding an earlier scheme as the industry comes under renewed fire for affordability amid high drug prices and large profits.<\/p>\n<figure role=\"presentation\"><figcaption><fbs-accordion><\/p>\n<p>Pfizer CEO Albert Bourla said the expansion will help improve access to medicines around the world. <\/p>\n<p><\/fbs-accordion><small>Getty Images<\/small><\/figcaption><\/figure>\n<h2>Key Facts<\/h2>\n<div>\n<div>\n<p>Pfizer said it would make its entire portfolio of medicines and vaccines available on a not-for-profit basis to 45 low-income countries.<\/p>\n<\/p><\/div>\n<div>\n<p>The move, announced at the World Economic Forum\u2019s annual meeting in Davos, Switzerland, will expand access to around 500 of the firm\u2019s products for some 1.2 billion people living in the world\u2019s poorest countries including Afghanistan, Haiti, North Korea, Kyrgyzstan, Rwanda, Uganda, Senegal, Eritrea and Cambodia.<\/p>\n<\/p><\/div>\n<div>\n<p>It will include patented and off-patent medicines for which Pfizer has global rights such as chemotherapies and oral cancer treatments, which Pfizer said have the potential to treat nearly 1 million new cancer cases in covered countries each year.<\/p>\n<\/p><\/div>\n<p>The scheme also includes a \u201cwide range of antibiotics,\u201d which the firm said will help address the costs and risks associated with antimicrobial resistance and help prevent around 1.5 million deaths from bacterial infections in hospitals and community health clinics each year.<\/p>\n<p>Pfizer said it will add new vaccines and medicines to the not-for-profit scheme as they are launched.<\/p>\n<\/div>\n<h2>Key Background<\/h2>\n<p>The announcement marks a significant expansion of Pfizer\u2019s \u201cAn Accord for a Healthier World\u201d <a href=\"https:\/\/www.pfizer.com\/about\/responsibility\/global-impact\/accord\" target=\"_blank\" title=\"https:\/\/www.pfizer.com\/about\/responsibility\/global-impact\/accord\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.pfizer.com\/about\/responsibility\/global-impact\/accord\" aria-label=\"initiative\">initiative<\/a>, which <a href=\"https:\/\/www.forbes.com\/sites\/roberthart\/2022\/05\/25\/pfizer-offers-low-cost-drugs-and-vaccines-including-covid-treatments-to-worlds-poorest-countries\/?sh=3f4e192c490f\" target=\"_self\" title=\"https:\/\/www.forbes.com\/sites\/roberthart\/2022\/05\/25\/pfizer-offers-low-cost-drugs-and-vaccines-including-covid-treatments-to-worlds-poorest-countries\/?sh=3f4e192c490f\" data-ga-track=\"InternalLink:https:\/\/www.forbes.com\/sites\/roberthart\/2022\/05\/25\/pfizer-offers-low-cost-drugs-and-vaccines-including-covid-treatments-to-worlds-poorest-countries\/?sh=3f4e192c490f\" aria-label=\"launched last year\" rel=\"noopener\">launched last year<\/a>. The Accord made 23 of Pfizer\u2019s patented products available on a not-for-profit basis including its antiviral Covid treatment paxlovid, vaccines and its top cancer fighting drugs. It comes at a tricky time for the pharmaceutical industry, which has long faced scrutiny over its prices and profits, and Pfizer in particular has been in the spotlight in recent years. The firm, which jointly produces one of the world\u2019s leading Covid vaccines and one of the only effective antiviral treatments, has been accused of <a href=\"https:\/\/www.theguardian.com\/business\/2022\/feb\/08\/pfizer-covid-vaccine-pill-profits-sales\" target=\"_blank\" title=\"https:\/\/www.theguardian.com\/business\/2022\/feb\/08\/pfizer-covid-vaccine-pill-profits-sales\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.theguardian.com\/business\/2022\/feb\/08\/pfizer-covid-vaccine-pill-profits-sales\" aria-label=\"profiteering during the Covid-19\">profiteering during the Covid-19<\/a> pandemic as its profits soared amid vast inequities in access. It is a defining and divisive area of doing business in the pharmaceutical sector, where patents are used to reward innovators by granting them exclusivity and allowing them to set prices without competition. Prices can be high, often too high for even those in wealthy countries to afford, let alone those in poorer nations. Firms typically justify their pricing based on the high costs associated with bringing new treatments and vaccines to market, many of which fail in development. Critics <a href=\"https:\/\/www.marketwatch.com\/story\/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340\" target=\"_blank\" title=\"https:\/\/www.marketwatch.com\/story\/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.marketwatch.com\/story\/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340\" aria-label=\"point\">point<\/a> to the apparent mismatch between pharma profits and research costs, slamming the sector\u2019s opacity <a href=\"https:\/\/www.wired.co.uk\/article\/drug-research-and-pricing\" target=\"_blank\" title=\"https:\/\/www.wired.co.uk\/article\/drug-research-and-pricing\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.wired.co.uk\/article\/drug-research-and-pricing\" aria-label=\"surrounding\">surrounding<\/a> how much it actually costs to bring something to market, the significant amounts of public money going towards research and development and <a href=\"https:\/\/www.marketwatch.com\/story\/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340\" target=\"_blank\" title=\"https:\/\/www.marketwatch.com\/story\/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.marketwatch.com\/story\/drug-companies-plan-to-raise-prices-on-vital-medicines-to-fund-r-d-but-they-already-spend-more-on-shareholder-returns-11673626340\" aria-label=\"big spending\">big spending<\/a> on shareholder rewards and non-research <a href=\"https:\/\/www.theatlantic.com\/health\/archive\/2019\/03\/drug-prices-high-cost-research-and-development\/585253\/\" target=\"_blank\" title=\"https:\/\/www.theatlantic.com\/health\/archive\/2019\/03\/drug-prices-high-cost-research-and-development\/585253\/\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.theatlantic.com\/health\/archive\/2019\/03\/drug-prices-high-cost-research-and-development\/585253\/\" aria-label=\"costs\">costs<\/a> like marketing.<\/p>\n<h2>Further Reading<\/h2>\n<p><a href=\"https:\/\/www.wired.co.uk\/article\/drug-research-and-pricing\" target=\"_blank\" title=\"https:\/\/www.wired.co.uk\/article\/drug-research-and-pricing\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.wired.co.uk\/article\/drug-research-and-pricing\" aria-label=\"Big Pharma Says Drug Prices Reflect R&#038;D Cost. Researchers Call BS\">Big Pharma Says Drug Prices Reflect R&#038;D Cost. Researchers Call BS<\/a> (Wired)<\/p>\n<p><a href=\"https:\/\/www.forbes.com\/sites\/roberthart\/2022\/05\/25\/pfizer-offers-low-cost-drugs-and-vaccines-including-covid-treatments-to-worlds-poorest-countries\/?sh=3f4e192c490f\" target=\"_self\" title=\"https:\/\/www.forbes.com\/sites\/roberthart\/2022\/05\/25\/pfizer-offers-low-cost-drugs-and-vaccines-including-covid-treatments-to-worlds-poorest-countries\/?sh=3f4e192c490f\" data-ga-track=\"InternalLink:https:\/\/www.forbes.com\/sites\/roberthart\/2022\/05\/25\/pfizer-offers-low-cost-drugs-and-vaccines-including-covid-treatments-to-worlds-poorest-countries\/?sh=3f4e192c490f\" aria-label=\"Pfizer Offers Low-Cost Drugs And Vaccines\u2014Including Covid Treatments\u2014To World\u2019s Poorest Countries\" rel=\"noopener\">Pfizer Offers Low-Cost Drugs And Vaccines\u2014Including Covid Treatments\u2014To World\u2019s Poorest Countries<\/a> (Forbes)<\/p>\n<\/div>\n<div>\n<p><span>Follow me on\u00a0<\/span><a href=\"https:\/\/www.twitter.com\/TheRobertHart\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>\u00a0or\u00a0<a href=\"https:\/\/www.linkedin.com\/in\/theroberthart\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>.\u00a0<span>Send me a secure\u00a0<a href=\"https:\/\/www.forbes.com\/tips\/\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">tip<\/a><\/span>.\u00a0<\/p>\n<\/div>\n<p><a href=\"https:\/\/www.forbes.com\/sites\/roberthart\/2023\/01\/17\/pfizer-offers-up-entire-drug-and-vaccine-portfolio-to-worlds-poorest-countries-at-non-profit-prices\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><br \/>\n Robert Hart<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Topline U.S. pharma giant Pfizer on Tuesday said it will make its entire portfolio of drugs and vaccines available to low-income countries on a not-for-profit basis, significantly expanding an earlier scheme as the industry comes under renewed fire for affordability amid high drug prices and large profits. Pfizer CEO Albert Bourla said the expansion will<\/p>\n","protected":false},"author":1,"featured_media":598844,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4568,27168],"tags":[],"class_list":{"0":"post-598843","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-offers","8":"category-pfizer"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/598843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/comments?post=598843"}],"version-history":[{"count":0,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/posts\/598843\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media\/598844"}],"wp:attachment":[{"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/media?parent=598843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/categories?post=598843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newsycanuse.com\/index.php\/wp-json\/wp\/v2\/tags?post=598843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}